Cargando…
SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
BACKGROUND: Patients with inflammatory bowel disease (IBD) have an attenuated serologic response to COVID-19 vaccination. It is unclear whether an impaired immune response in vaccinated IBD patients impacts the susceptibility to SARS-CoV-2 infection and occurrence of severe COVID-19. OBJECTIVES: To...
Autores principales: | van de Pol, Natasja, Pan, Qiuwei, Derikx, Lauranne A. A. P., Bakker, Linda, van der Woude, C. Janneke, de Vries, Annemarie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350577/ https://www.ncbi.nlm.nih.gov/pubmed/37461739 http://dx.doi.org/10.1177/17562848231174295 |
Ejemplares similares
-
Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease
por: Stone, Katherine L., et al.
Publicado: (2023) -
COVID-19 vaccination in adults with inflammatory bowel disease
por: Lutz, Megan, et al.
Publicado: (2023) -
COVID-19 is not associated with worse long-term inflammatory bowel
disease outcomes: a multicenter case–control study
por: Hong, Simon J., et al.
Publicado: (2022) -
Managing IBD in the COVID-19 era
por: Scalzo, Nicholas, et al.
Publicado: (2023) -
The impact of the COVID-19 pandemic on Clostridioides
difficile infection and utilization of fecal microbiota
transplantation
por: Bachour, Salam P., et al.
Publicado: (2023)